| 000 | 01315 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250517065006.0 | ||
| 264 | 0 | _c20160627 | |
| 008 | 201606s 0 0 eng d | ||
| 022 | _a1744-7666 | ||
| 024 | 7 |
_a10.1517/14656566.2016.1107043 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVrdoljak, E | |
| 245 | 0 | 0 |
_aPharmacoeconomic and clinical implications of sequential therapy for metastatic renal cell carcinoma patients in Central and Eastern Europe. _h[electronic resource] |
| 260 |
_bExpert opinion on pharmacotherapy _c2016 |
||
| 300 |
_a93-104 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xeconomics |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xdrug therapy |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aEconomics, Pharmaceutical |
| 650 | 0 | 4 | _aEurope, Eastern |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aReimbursement Mechanisms |
| 650 | 0 | 4 | _aTurkey |
| 700 | 1 | _aTorday, L | |
| 700 | 1 | _aSzczylik, C | |
| 700 | 1 | _aKharkevich, G | |
| 700 | 1 | _aBavbek, S | |
| 700 | 1 | _aSella, A | |
| 773 | 0 |
_tExpert opinion on pharmacotherapy _gvol. 17 _gno. 1 _gp. 93-104 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/14656566.2016.1107043 _zAvailable from publisher's website |
| 999 |
_c25497321 _d25497321 |
||